Analyst Ratings for Pliant Therapeutics (PLRX)
PLRX Rating Summary
PLRX Price Target Summary
- Highest: $3.00 (Piper Sandler)
- Lowest: $2.00 (RBC Capital)
- Average: $2.67
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$2.67 (+196.3%)
* Over Last 12-Mos
Rating Score: 2.7 / 10
Percentile Rank: 22%
Rating Score: 2.7 / 10
Percentile Rank: 22%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/10/2025 | JPMorgan | Brian Cheng | Downgrade | Underweight (Neutral) |
N/A (N/A) |
1.53 (0.90) |
-41.18% | Details |
| 3/4/2025 | Needham | Alan Carr | Downgrade | Hold (Buy) |
N/A (N/A) |
1.38 (0.90) |
-34.78% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
